Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
Evaluate Forecasts Pharmaceutical Market to be Worth $1.6tn in 2028
New World Preview report finds strong top-line growth as pricing and patent headwinds build
Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
Evaluate Forecasts Pharmaceutical Market to be Worth $1.6tn in 2028
New World Preview report finds strong top-line growth as pricing and patent headwinds build
Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
2022年 希少疾病用医薬品動向 Evaluate オーファンドラッグ 2022 レポート 日本語版リリース
東京、日本－2022年5月26日 – 製薬業界における戦略策定や事業性評価に不可欠な信頼性の高いマーケット情報及び分析を提供するEvaluate（エバリュエート本社：ロンドン）は、2022年4月に発行した希少疾病用医薬品動向レポート 「オーファンドラッグ 2022 レポート」（原文：英語）の日本語版をリリースしました。
Evaluate appoints Matthew Wright as Chief Financial Officer
London, UK and Boston, MA – 11 May 2022 – Evaluate, a leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today…
Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster
United under Norstella, each brand’s key solutions and expertise will help life-sciences-focused companies get answers—not just insights—from pipeline to patient
Evaluate announces global strategic collaboration with Treehill Partners
London, UK and New York, USA –21 April 2022 – Evaluate and Treehill Partners today announced that they have entered into a global strategic collaboration to combine…
Evaluate announces global strategic collaboration with Treehill Partners
London, UK and New York, USA –21 April 2022 – Evaluate and Treehill Partners today announced that they have entered into a global strategic collaboration to combine…
製薬業界動向レポート Evaluate Vantage® 2021 レビュー 日本語版リリース
東京、2022年3月15日 – 製薬業界の戦略策定や事業性評価に必要な信頼性の高いマーケット情報を提供するEvaluate（エバリュエート本社：ロンドン）は、2022年2月に発行した製薬業界動向レポート 「Evaluate Vantage® 2021 レビュー」（原文：英語）の日本語版をリリースしました。
Press Releases
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].
